vs
Lantheus Holdings, Inc.（LNTH）与Reddit, Inc.（RDDT）财务数据对比。点击上方公司名可切换其他公司
Reddit, Inc.的季度营收约是Lantheus Holdings, Inc.的1.8倍（$725.6M vs $406.8M），Reddit, Inc.净利率更高（34.7% vs 13.3%，领先21.4%），Reddit, Inc.同比增速更快（69.7% vs 4.0%），Reddit, Inc.自由现金流更多（$263.6M vs $81.4M），过去两年Reddit, Inc.的营收复合增速更高（72.8% vs 4.9%）
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台，注册用户可发布链接、文字帖、图片、视频等各类内容，其他用户可对内容进行点赞或点踩，内容按主题归类到用户创建的子板块中，获赞更高的内容会排在板块前列，热度足够的内容还将展示在全站首页。
LNTH vs RDDT — 直观对比
营收规模更大
RDDT
是对方的1.8倍
$406.8M
营收增速更快
RDDT
高出65.6%
4.0%
净利率更高
RDDT
高出21.4%
13.3%
自由现金流更多
RDDT
多$182.3M
$81.4M
两年增速更快
RDDT
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.8M | $725.6M |
| 净利润 | $54.1M | $251.6M |
| 毛利率 | 59.2% | 91.9% |
| 营业利润率 | 19.0% | 31.9% |
| 净利率 | 13.3% | 34.7% |
| 营收同比 | 4.0% | 69.7% |
| 净利润同比 | 558.8% | 254.2% |
| 每股收益（稀释后） | $0.86 | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNTHRDDT
| Q4 25 | $406.8M | $725.6M | ||
| Q3 25 | $384.0M | $584.9M | ||
| Q2 25 | $378.0M | $499.6M | ||
| Q1 25 | $372.8M | $392.4M | ||
| Q4 24 | $391.1M | $427.7M | ||
| Q3 24 | $378.7M | $348.4M | ||
| Q2 24 | $394.1M | $281.2M | ||
| Q1 24 | $370.0M | $243.0M |
净利润LNTHRDDT
| Q4 25 | $54.1M | $251.6M | ||
| Q3 25 | $27.8M | $162.7M | ||
| Q2 25 | $78.8M | $89.3M | ||
| Q1 25 | $72.9M | $26.2M | ||
| Q4 24 | $-11.8M | $71.0M | ||
| Q3 24 | $131.1M | $29.9M | ||
| Q2 24 | $62.1M | $-10.1M | ||
| Q1 24 | $131.1M | $-575.1M |
毛利率LNTHRDDT
| Q4 25 | 59.2% | 91.9% | ||
| Q3 25 | 57.9% | 91.0% | ||
| Q2 25 | 63.8% | 90.8% | ||
| Q1 25 | 63.8% | 90.5% | ||
| Q4 24 | 63.5% | 92.6% | ||
| Q3 24 | 63.9% | 90.1% | ||
| Q2 24 | 64.9% | 89.5% | ||
| Q1 24 | 65.4% | 88.6% |
营业利润率LNTHRDDT
| Q4 25 | 19.0% | 31.9% | ||
| Q3 25 | 11.4% | 23.7% | ||
| Q2 25 | 23.3% | 13.6% | ||
| Q1 25 | 27.4% | 1.0% | ||
| Q4 24 | 29.1% | 12.4% | ||
| Q3 24 | 35.3% | 2.0% | ||
| Q2 24 | 26.1% | -11.0% | ||
| Q1 24 | 28.8% | -242.5% |
净利率LNTHRDDT
| Q4 25 | 13.3% | 34.7% | ||
| Q3 25 | 7.2% | 27.8% | ||
| Q2 25 | 20.8% | 17.9% | ||
| Q1 25 | 19.6% | 6.7% | ||
| Q4 24 | -3.0% | 16.6% | ||
| Q3 24 | 34.6% | 8.6% | ||
| Q2 24 | 15.8% | -3.6% | ||
| Q1 24 | 35.4% | -236.7% |
每股收益（稀释后）LNTHRDDT
| Q4 25 | $0.86 | $1.24 | ||
| Q3 25 | $0.41 | $0.80 | ||
| Q2 25 | $1.12 | $0.45 | ||
| Q1 25 | $1.02 | $0.13 | ||
| Q4 24 | $-0.18 | $4.76 | ||
| Q3 24 | $1.79 | $0.16 | ||
| Q2 24 | $0.88 | $-0.06 | ||
| Q1 24 | $1.87 | $-8.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $359.1M | $953.6M |
| 总债务越低越好 | $568.7M | — |
| 股东权益账面价值 | $1.1B | $2.9B |
| 总资产 | $2.2B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.52× | — |
8季度趋势，按日历期对齐
现金及短期投资LNTHRDDT
| Q4 25 | $359.1M | $953.6M | ||
| Q3 25 | $382.0M | $911.7M | ||
| Q2 25 | $695.6M | $734.1M | ||
| Q1 25 | $938.5M | $635.7M | ||
| Q4 24 | $912.8M | $562.1M | ||
| Q3 24 | $866.4M | $515.9M | ||
| Q2 24 | $757.0M | $468.0M | ||
| Q1 24 | $718.3M | $968.5M |
总债务LNTHRDDT
| Q4 25 | $568.7M | — | ||
| Q3 25 | $567.9M | — | ||
| Q2 25 | $566.8M | — | ||
| Q1 25 | $566.1M | — | ||
| Q4 24 | $565.3M | — | ||
| Q3 24 | $613.0K | — | ||
| Q2 24 | $563.2M | — | ||
| Q1 24 | $562.5M | — |
股东权益LNTHRDDT
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.1B | $2.6B | ||
| Q2 25 | $1.2B | $2.4B | ||
| Q1 25 | $1.2B | $2.2B | ||
| Q4 24 | $1.1B | $2.1B | ||
| Q3 24 | $1.2B | $2.0B | ||
| Q2 24 | $1.0B | $1.9B | ||
| Q1 24 | $945.5M | $1.8B |
总资产LNTHRDDT
| Q4 25 | $2.2B | $3.2B | ||
| Q3 25 | $2.3B | $2.9B | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.1B | $2.4B | ||
| Q4 24 | $2.0B | $2.3B | ||
| Q3 24 | $2.0B | $2.2B | ||
| Q2 24 | $1.9B | $2.1B | ||
| Q1 24 | $1.8B | $2.0B |
负债/权益比LNTHRDDT
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | 0.59× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $90.2M | $266.8M |
| 自由现金流经营现金流 - 资本支出 | $81.4M | $263.6M |
| 自由现金流率自由现金流/营收 | 20.0% | 36.3% |
| 资本支出强度资本支出/营收 | 2.2% | 0.4% |
| 现金转化率经营现金流/净利润 | 1.67× | 1.06× |
| 过去12个月自由现金流最近4个季度 | $354.1M | $684.2M |
8季度趋势，按日历期对齐
经营现金流LNTHRDDT
| Q4 25 | $90.2M | $266.8M | ||
| Q3 25 | $105.3M | $185.2M | ||
| Q2 25 | $87.1M | $111.3M | ||
| Q1 25 | $107.6M | $127.6M | ||
| Q4 24 | $157.7M | $90.0M | ||
| Q3 24 | $175.1M | $71.6M | ||
| Q2 24 | $84.7M | $28.4M | ||
| Q1 24 | $127.2M | $32.1M |
自由现金流LNTHRDDT
| Q4 25 | $81.4M | $263.6M | ||
| Q3 25 | $94.7M | $183.1M | ||
| Q2 25 | $79.1M | $110.8M | ||
| Q1 25 | $98.8M | $126.6M | ||
| Q4 24 | $141.4M | $89.2M | ||
| Q3 24 | $159.3M | $70.3M | ||
| Q2 24 | $73.5M | $27.2M | ||
| Q1 24 | $119.0M | $29.2M |
自由现金流率LNTHRDDT
| Q4 25 | 20.0% | 36.3% | ||
| Q3 25 | 24.7% | 31.3% | ||
| Q2 25 | 20.9% | 22.2% | ||
| Q1 25 | 26.5% | 32.3% | ||
| Q4 24 | 36.1% | 20.8% | ||
| Q3 24 | 42.0% | 20.2% | ||
| Q2 24 | 18.7% | 9.7% | ||
| Q1 24 | 32.2% | 12.0% |
资本支出强度LNTHRDDT
| Q4 25 | 2.2% | 0.4% | ||
| Q3 25 | 2.8% | 0.4% | ||
| Q2 25 | 2.1% | 0.1% | ||
| Q1 25 | 2.3% | 0.2% | ||
| Q4 24 | 4.2% | 0.2% | ||
| Q3 24 | 4.2% | 0.4% | ||
| Q2 24 | 2.8% | 0.4% | ||
| Q1 24 | 2.2% | 1.2% |
现金转化率LNTHRDDT
| Q4 25 | 1.67× | 1.06× | ||
| Q3 25 | 3.79× | 1.14× | ||
| Q2 25 | 1.11× | 1.25× | ||
| Q1 25 | 1.47× | 4.88× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | 1.34× | 2.40× | ||
| Q2 24 | 1.36× | — | ||
| Q1 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
RDDT
| Advertising | $689.7M | 95% |
| Other Revenue | $35.9M | 5% |
